Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes. [electronic resource]
Producer: 20200907Description: 1054-1057 p. digitalISSN:- 1463-1326
- Adult
- Autoantibodies -- immunology
- Body Weight
- C-Peptide -- metabolism
- Deprescriptions
- Diabetes Mellitus, Type 1 -- drug therapy
- Drug Therapy, Combination
- Female
- Glucagon-Like Peptides -- analogs & derivatives
- Glutamate Decarboxylase -- immunology
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- therapeutic use
- Immunoglobulin Fc Fragments -- therapeutic use
- Insulin -- therapeutic use
- Liraglutide -- therapeutic use
- Male
- Middle Aged
- Recombinant Fusion Proteins -- therapeutic use
- Retrospective Studies
- Treatment Outcome
- Weight Loss
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.